MYOGENE BIO
MyoGene Bio develops therapies for muscle diseases, starting with a gene-editing therapy for Duchenne muscular dystrophy.
MYOGENE BIO
Industry:
Biotechnology Genetics Health Care Therapeutics Wellness
Founded:
2018-01-01
Address:
Los Angeles, California, United States
Country:
United States
Website Url:
http://www.myogenebio.com
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Similar Organizations
Lumiere Children's Therapy
Lumiere Children's Therapy is a full-service, multidisciplinary pediatric therapy practice company.
Investors List
MassChallenge
MassChallenge investment in Non Equity Assistance - MyoGene Bio
Official Site Inspections
http://www.myogenebio.com
- Host name: 32.221.168.184.host.secureserver.net
- IP address: 184.168.221.32
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "MyoGene Bio"
MyoGene Bio
MyoDys45-55 is designed to permanently fix the underlying cause of the disease for half of all Duchenne patients using this single platform. Future programs will develop similar strategies โฆSee details»
MyoGene Bio - About Us
MyoGene Bio utilizes new technologies to develop effective treatments that slow the progression of the disease by targeting the underlying causes. As a company, we strive to create โฆSee details»
MyoGene Bio LLC About Us
Our team is a dedicated group of scientists with over 50 cumulative years of experience in research and treatment of muscle diseases. We are experienced in innovative research, creating and managing biomedical research laboratories, โฆSee details»
MyoGene Bio - Crunchbase Company Profile & Funding
View contacts for MyoGene Bio to access new leads and connect with decision-makers. MyoGene Bio develops therapies for muscle diseases, starting with a gene-editing therapy for โฆSee details»
MyoGene Bio Company Profile 2024: Valuation, โฆ
Developer of a gene-editing therapy intended to treat Duchenne muscular dystrophy. The company's therapy utilizes new technologies to have a strong โฆSee details»
MYOGENE BIO LLC - VentureRadar
Website: http://www.myogenebio.com. Our lead program is a gene editing platform, SPY-DYS45-55, for Duchenne muscular dystrophy (DMD), a devastating muscle wasting disease. โฆSee details»
MyoGene Bio - LinkedIn
Courtney Young is the CEO and Co-founder of MyoGene Bio, a biotech company developing a gene editing therapy, MyoDys45-55, for Duchenne muscular dystrophy (#DMD), a devastating โฆSee details»
CureDuchenne Ventures Invests in MyoGene Bio and its AAV โฆ
May 11, 2023ย ยท MyoGene Bioโs lead program is a gene editing therapy, MyoDys 45-55, for Duchenne muscular dystrophy, a devastating muscle wasting disease. MyoGene Bio utilizes โฆSee details»
MyoGene Bio - Graduated Companies
MyoGene Bio's therapy, SPY-DYS45-55, is a gene editing approach designed to permanently remove a mutational hotspot in the gene that causes Duchenne and allow for dystrophin, the โฆSee details»
MyoGene Bio LLC โ CIRM - California
Program Type Investigator Grant Title Award Value; Therapeutic Translational Research Projects: Dr Courtney Young: Development of MyoDys45-55, a gene editing therapy for Duchenne โฆSee details»
MYOGENE BIO LLC - VentureRadar
"MyoGene Bio LLC is pioneering gene editing therapies to combat Duchenne muscular dystrophy (DMD), a severe muscle-wasting disease. Their lead program, MyoDys45-55, targets the root โฆSee details»
Company: MyoGene Bio - crisprmedicinenews.com
MyoGene Bio is a biotechnology company specialising in the development of genetic therapies for muscle diseases such as Duchenne muscular dystrophy (DMD) and Becker muscular โฆSee details»
MyoGene Bio - Our Product
MyoDys45-55 is a gene editing platform designed to permanently delete a region of DNA where there is a hotspot of Duchenne mutations and restore dystrophin protein. The dystrophin โฆSee details»
Courtney Young - MyoGene Bio - LinkedIn
Co-founder and CEO of MyoGene Bio, a biotech startup dedicated to developing cutting edgeโฆ ยท Experience: MyoGene Bio ยท Education: Creative Destruction โฆSee details»
MyoGene Bio - Creative Destruction Lab
MyoGene Bio is developing therapies for muscle diseases with a gene editing therapy for DMD.See details»
Courtney Young of MyoGene bio - Rare Revolution
Feb 23, 2022ย ยท MyoGene Bio is a biotechnology startup dedicated to developing therapies for rare muscle diseases. Our first approach is a gene editing therapy for Duchenne muscular โฆSee details»
MyoGene Bio - Overview, News & Similar companies - ZoomInfo
MyoGene Bio, a San Diego, CA-based biotech company developing a novel gene editing therapy for Duchenne muscular dystrophy (DMD), received an investment from CureDuchenne โฆSee details»
Myogenic regulatory factors - Wikipedia
Myogenic regulatory factors (MRF) are basic helix-loop-helix (bHLH) transcription factors that regulate myogenesis: MyoD, Myf5, myogenin, and MRF4. [1]These proteins contain a โฆSee details»
ุงูููุตููุฉ ุงูุนุงู ุฉ ูุฌู ููุฑูุฉ ุงูุณูุฏุงู ุจุฌุฏุฉ | ุณูุงุฑุฉ ุฌู ููุฑูุฉ ุงูุณูุฏุงู ูู ...
ุนุฒูุฒู ุงูู ูุงุทู, ุนุฒูุฒุชู ุงูู ูุงุทูุฉ.. ุฌุฏุฏ/ู ุฌูุงุฒู ูุจู ูุชุฑุฉ ูุงููุฉ ู ู ุฅูุชูุงุก ุตูุงุญูุชู; ุงูุฅุณุฑุงุน ูู ุชุฌุฏูุฏ ุงูุฌูุงุฒ ูุฌูุจูู ู ุฎุงููุฉ ูุธุงู ุงูุฅูุงู ุฉ ุจุงูู ู ููุฉ ุงูุนุฑุจูุฉ ุงูุณุนูุฏูุฉSee details»
MyoGene Bio LLC Our Products
We have developed MyoDys 45-55, a gene editing therapy that can restore a functional dystrophin protein in DMD patients and significantly improve the quality of life and lifespan. โฆSee details»